Alterity Therapeutics Limited Stock
Stocks
ATH
AU0000043945
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5400 AUD | +0.93% |
|
-8.47% | +35.00% |
| Market Cap | 82.98M 71.91M 67.32M 61.43M 116M 7.91B 118M 789M 309M 3.96B 312M 305M 13.22B | P/E 2026 * |
-0.41x | P/E 2027 * | -0.42x |
|---|---|---|---|---|---|
| Enterprise Value | 37.79M 32.75M 30.66M 27.98M 52.65M 3.6B 53.53M 360M 141M 1.8B 142M 139M 6.02B | EV / Sales 2026 * |
11.5x | EV / Sales 2027 * | 16.8x |
| Free-Float |
91.85% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Alterity Therapeutics Limited
| 1 day | +0.93% | ||
| 1 week | -8.47% | ||
| Current month | -0.92% | ||
| 1 month | -14.96% | ||
| 3 months | -1.82% | ||
| 6 months | +35.00% | ||
| Current year | +35.00% |
| 1 week | 0.51 |  | 0.57 |
| 1 month | 0.5 | | 0.64 |
| Current year | 0.35 | | 0.78 |
| 1 year | 0.35 | | 0.78 |
| 3 years | 0.1 | | 0.95 |
| 5 years | 0.1 | | 1.7 |
| 10 years | 0.1 | | 20.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 65 | 07/01/2021 |
Abby Macnish
DFI | Director of Finance/CFO | - | 30/09/2024 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Marks
BRD | Director/Board Member | 70 | 29/07/2005 |
Lawrence Gozlan
BRD | Director/Board Member | 47 | 08/08/2011 |
David Stamler
BRD | Director/Board Member | 65 | 21/11/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/6/26 | Free | Director | 1,000,000 | 0.0092% | ||
| 7/1/26 | Expiration | Chief Executive Officer | 91,392,720 | 0.8404% | ||
| 17/9/25 | Expiration | Director | 7,000,000 | 0.1052% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.93% | -8.47% | -28.00% | +54.29% | 82.21M | |
| -0.72% | +3.41% | +6.32% | +16.27% | 50.03B | |
| +0.48% | +7.37% | +498.63% | +592.65% | 44.36B | |
| +0.74% | +12.15% | +25.02% | +83.25% | 40.82B | |
| +0.89% | +7.05% | +35.65% | +11.12% | 39.83B | |
| +4.73% | +15.53% | +26.95% | +54.62% | 32.51B | |
| -0.62% | +3.75% | - | - | 16.85B | |
| +0.70% | +5.46% | +34.84% | +127.23% | 16.81B | |
| -0.20% | +1.57% | +5.49% | +21.35% | 14.05B | |
| +0.60% | +19.09% | +87.21% | +30.01% | 13.22B | |
| Average | +0.76% | +252.02% | +76.90% | +110.09% | 26.86B | |
| Weighted average by Cap. | +0.81% | +295.23% | +109.52% | +141.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.29M 2.85M 2.67M 2.44M 4.58M 314M 4.66M 31.3M 12.26M 157M 12.35M 12.08M 524M | 2.5M 2.17M 2.03M 1.85M 3.49M 239M 3.55M 23.82M 9.33M 120M 9.4M 9.2M 399M |
| Net income | -14.64M -12.69M -11.88M -10.84M -20.4M -1.4B -20.74M -139M -54.58M -699M -54.98M -53.78M -2.33B | -29.66M -25.7M -24.06M -21.96M -41.32M -2.83B -42.01M -282M -111M -1.42B -111M -109M -4.72B |
| Net Debt | -45.19M -39.16M -36.66M -33.45M -62.95M -4.31B -64M -430M -168M -2.16B -170M -166M -7.2B | -40.88M -35.43M -33.17M -30.26M -56.95M -3.9B -57.9M -389M -152M -1.95B -153M -150M -6.51B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/08/26 | $0.5400 | +0.93% | 13,665 |
| 10/08/26 | $0.5350 | +3.88% | 47,330 |
| 07/08/26 | $0.5150 | -1.90% | 65,719 |
| 06/08/26 | $0.5250 | -5.41% | 218,904 |
| 05/08/26 | $0.5550 | -0.89% | 32,640 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATH Stock
Select your edition
All financial news and data tailored to specific country editions
